about
Interventions for melanoma in situ, including lentigo malignaInterventions for melanoma in situ, including lentigo malignaReviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna MelanomaThe Yin and Yang of Toll-like receptors in cancerA systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer.Immunomodulation by imiquimod in patients with high-risk primary melanomaDiagnosis and management of lentigo maligna: a reviewA systematic review of non-surgical treatments for lentigo maligna.Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model.The abscopal effect associated with a systemic anti-melanoma immune response.Melanoma in Situ Treated with Topical Imiquimod for Management of Persistently Positive Margins: A Review of Treatment Methods.Immunotherapy of melanoma: a critical review of current concepts and future strategies.Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna.Treating skin cancer with topical cream.Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.Improved TLC Bioautographic Assay for Qualitative and Quantitative Estimation of Tyrosinase Inhibitors in Natural Products.Periocular lentigo maligna treated with imiquimod.Topical Imiquimod Treatment of Lentigo Maligna.Cryosurgical treatment of lentigo maligna.NeoplasmsLentigos, Melanocytic Naevi and Melanoma
P2860
Q24187170-CA526282-D2E5-48C1-8D87-A8D27961473AQ24202030-3E4351DC-78F8-406B-AE3C-B626CFDFE209Q26828784-32461CB0-4410-48C3-9CEF-E73DE609E66AQ26851526-6276F42E-B5AE-467F-B551-A94BAC64FBE7Q30240021-0FDE9532-CF81-417C-BAD3-AFBF37DA2AA9Q30433673-52A9B29F-F8A8-455E-9949-4C605331FEC2Q33293591-7B7BB64B-B90E-4405-A66A-056BC925947BQ35590166-3D3A5F2F-3AAC-4D22-BF4D-19583147B09EQ35678220-24C46629-E372-4DD4-A819-9EC9BE04B3C8Q35753267-9585C0C6-46BC-4D51-9B62-6C03F10A1623Q35865283-1FF50598-9FC3-4ECB-8BE5-3C8ECFBEAFD1Q36153077-2EB49F5F-754C-47AB-82F2-A4765623F332Q36372198-F0F0B27B-369B-4477-A6FA-9C05AE81F352Q36739767-D19A1883-9533-46CF-859C-E82C79AE63E2Q37138613-57CE8B93-AC52-4310-92F1-91717D6C53B6Q37735187-EAA69763-2073-443C-B7BA-05061EB1DC3AQ37763742-A35BA4E0-A584-4436-9169-C5A54413240FQ38088212-9C17070C-9662-4789-A65C-9B6F8D66CF26Q38724021-42076D99-BCF2-4B26-9CBD-555C32E7F449Q42475070-4FAD1285-5951-4843-B622-9660CEA58C49Q42739797-11747E4F-A977-4C7D-85DF-8AD79BCB4823Q48593929-46062C80-4C5D-47E1-A3E5-4E889DED3350Q56828372-A0A0CF8B-0661-49CF-B3DF-5506EF28055BQ56828381-4B205E6F-4BBB-4A2B-8BA0-D7AB8CCDD95E
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Imiquimod in the treatment of lentigo maligna.
@ast
Imiquimod in the treatment of lentigo maligna.
@en
Imiquimod in the treatment of lentigo maligna.
@nl
type
label
Imiquimod in the treatment of lentigo maligna.
@ast
Imiquimod in the treatment of lentigo maligna.
@en
Imiquimod in the treatment of lentigo maligna.
@nl
prefLabel
Imiquimod in the treatment of lentigo maligna.
@ast
Imiquimod in the treatment of lentigo maligna.
@en
Imiquimod in the treatment of lentigo maligna.
@nl
P2860
P1476
Imiquimod in the treatment of lentigo maligna.
@en
P2093
J R Marsden
S F Rajpar
P2860
P304
P356
10.1111/J.1365-2133.2006.07476.X
P407
P577
2006-10-01T00:00:00Z